← Back to Investors

Gilde Healthcare

Gilde Healthcare is a leading European venture capital and growth equity firm focused exclusively on healthcare. They invest in therapeutics, medtech, and digital health companies, with a strong presence in the European healthcare innovation ecosystem.

Location
Utrecht, Netherlands
Founded
2001
AUM
€1.2B+
Investment Range
€5M - €50M
Focus
biotech-focused
Fund Stages
series-a, series-b, series-c, growth

Investment Thesis

Gilde Healthcare focuses on healthcare companies with differentiated technology or approaches that can significantly improve patient outcomes. They invest across therapeutics, medical devices, diagnostics, and digital health, with a preference for European companies while also investing globally.

Team

Partners / Managing Directors (Health & Bio Focus)

  • Pieter van der Meer, PhD - Managing Partner
  • Geert Duyck - Partner
  • Johan Körver - Partner
  • Rolf Sobel - Partner

Other Key Team Members

  • Jasper Bos - Partner

Focus Areas

  • Therapeutics (oncology, CNS, rare diseases)
  • Medical devices
  • Diagnostics
  • Digital health
  • Healthcare services
  • European healthcare innovation

Notable Exits

  • Acerta Pharma - Acquired by AstraZeneca (2016, $7B total)
  • Kite Pharma Europe - Part of Kite/Gilead acquisition
  • AM-Pharma - Multiple exits

Sources